These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 12887811)

  • 61. Helicobacter pylori and the relation to other risk factors in patients with acute bleeding peptic ulcer.
    Henriksson AE; Edman AC; Nilsson I; Bergqvist D; Wadström T
    Scand J Gastroenterol; 1998 Oct; 33(10):1030-3. PubMed ID: 9829355
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users.
    Calvet X; Rue M
    Aliment Pharmacol Ther; 2000 Aug; 14(8):1105-6. PubMed ID: 10930910
    [No Abstract]   [Full Text] [Related]  

  • 63. Previous use of non-steroidal anti-inflammatory drugs and anticoagulants: the influence on clinical outcome of bleeding gastroduodenal ulcers.
    Vreeburg EM; de Bruijne HW; Snel P; Bartelsman JW; Rauws EA; Tytgat GN
    Eur J Gastroenterol Hepatol; 1997 Jan; 9(1):41-4. PubMed ID: 9031897
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Effects of Helicobacter pylori(Hp) eradication on gastric mucosal pathophysiology in Hp-positive, NSAIDs-induced gastric ulcer].
    Yanaka A; Muto H
    Nihon Rinsho; 1999 Jan; 57(1):201-7. PubMed ID: 10036963
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration.
    Armstrong CP; Blower AL
    Gut; 1987 May; 28(5):527-32. PubMed ID: 3596334
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Helicobacter pylori and peptic-ulcer disease.
    Boulton-Jones JR; Hawkey CJ
    Lancet; 2002 Jun; 359(9321):1943; author reply 1944. PubMed ID: 12057572
    [No Abstract]   [Full Text] [Related]  

  • 67. Relation of upper gastrointestinal bleeding to non-steroidal anti-inflammatory drugs and aspirin: a case-control study.
    Holvoet J; Terriere L; Van Hee W; Verbist L; Fierens E; Hautekeete ML
    Gut; 1991 Jul; 32(7):730-4. PubMed ID: 1855677
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Management of Peptic Ulcer Bleeding in Patients Taking Aspirin or Anticoagulant].
    Yang HJ
    Korean J Gastroenterol; 2020 Nov; 76(5):242-245. PubMed ID: 33234771
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The potential risk factors leading to peptic ulcer formation in autoimmune disease patients receiving corticosteroid treatment.
    Luo JC; Chang FY; Lin HY; Lu RH; Lu CL; Chen CY; Lee SD
    Aliment Pharmacol Ther; 2002 Jul; 16(7):1241-8. PubMed ID: 12144573
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Low-Dose Aspirin and Non-steroidal Anti-inflammatory Drugs Increase the Risk of Bleeding in Patients with Gastroduodenal Ulcer.
    Kawasaki K; Kurahara K; Yanai S; Kochi S; Fuchigami T; Matsumoto T
    Dig Dis Sci; 2015 Apr; 60(4):1010-5. PubMed ID: 25366148
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Risk of acute upper gastrointestinal bleeding in patients with ulcerative disease and treatment with non-steroidal anti-inflammatory drugs (NSAIDs). Results from the Comprehensive Hospital Drug Monitoring Berne (CHDM).
    Stodolnik E; Maurer P; Hoigné R; Hess T; Müller U; Amonn F; Halter F; Maibach R; Künzi UP
    Eur J Clin Pharmacol; 1990; 38(1):31-5. PubMed ID: 2328744
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Continuing use of antithrombotic medications for patients with bleeding gastroduodenal ulcer requiring endoscopic hemostasis: a case-control study.
    Kawasaki K; Nakamura S; Kurahara K; Nagasue T; Yanai S; Harada A; Yaita H; Fuchigami T; Matsumoto T
    Scand J Gastroenterol; 2017 Sep; 52(9):948-953. PubMed ID: 28532190
    [TBL] [Abstract][Full Text] [Related]  

  • 73. H. pylori eradication in NSAID-associated ulcers.
    Drug Ther Bull; 2005 May; 43(5):37-40. PubMed ID: 15903114
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Management of nonsteroidal anti-inflammatory drug-induced upper gastrointestinal bleeding and perforation.
    Bretagne JF; Raoul JL
    Dig Dis; 1995 Jan; 13 Suppl 1():89-105. PubMed ID: 7697905
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Perforated peptic ulcer and short-term mortality among tramadol users.
    Tørring ML; Riis A; Christensen S; Thomsen RW; Jepsen P; Søndergaard J; Sørensen HT
    Br J Clin Pharmacol; 2008 Apr; 65(4):565-72. PubMed ID: 17922882
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Management of gastroduodenal ulcers caused by non-steroidal anti-inflammatory drugs.
    Hawkey CJ
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Feb; 14(1):173-92. PubMed ID: 10749097
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs.
    Langman MJ; Weil J; Wainwright P; Lawson DH; Rawlins MD; Logan RF; Murphy M; Vessey MP; Colin-Jones DG
    Lancet; 1994 Apr; 343(8905):1075-8. PubMed ID: 7909103
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s.
    Hernández-Díaz S; Rodríguez LA
    Arch Intern Med; 2000 Jul; 160(14):2093-9. PubMed ID: 10904451
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Commentary: bleeding ulcers, interaction between NSAIDs and Helicobacter pylori infection, and nonulcer dyspepsia.
    Veldhuyzen van Zanten SJ
    Gastroenterology; 1997 Dec; 113(6 Suppl):S90-2. PubMed ID: 9394767
    [No Abstract]   [Full Text] [Related]  

  • 80. Analgesic, antiulcer, antithrombotic drugs and organ damage: a population-based case-control study.
    Battelli D; Riccardi R; Piscaglia AC; Stefanelli ML; Mussoni L; Zani A; Vitale V; Monachese N
    Minerva Med; 2015 Dec; 106(6):323-31. PubMed ID: 26787649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.